For research use only. Not for therapeutic Use.
Glimepiride (CAT: I005553) is an oral medication belonging to the class of sulfonylurea drugs used for the management of type 2 diabetes mellitus. It works by stimulating the release of insulin from pancreatic beta cells and improving insulin sensitivity in peripheral tissues, thereby helping to lower blood glucose levels. Glimepiride is typically prescribed along with diet and exercise to control blood sugar levels in individuals with diabetes. It is important to follow the prescribed dosage and instructions provided by a healthcare professional when using glimepiride.
| Catalog Number | I005553 |
| CAS Number | 93479-97-1 |
| Synonyms | 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide |
| Molecular Formula | C24H34N4O5S |
| Purity | ≥95% |
| Target | Amyloid-β |
| Solubility | DMSO 11 mg/mL; Water <1 mg/mL; Ethanol <1 mg/mL |
| Storage | store at -20℃ |
| IUPAC Name | 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide |
| InChI | InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30) |
| InChIKey | WIGIZIANZCJQQY-UHFFFAOYSA-N |
| SMILES | CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C |
